InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
0.8500
-0.0300 (-3.41%)
At close: Jun 4, 2025, 4:00 PM
0.8589
+0.0089 (1.05%)
After-hours: Jun 4, 2025, 7:27 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Monoclonal Antibodies
68.21K

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
United States
68.21K